Rhythmic Auditory Stimulation Optimalization for Gait Improvement in Parkinson's
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Parkinson's Disease
- Sponsor
- University Hospital, Montpellier
- Enrollment
- 80
- Locations
- 3
- Primary Endpoint
- gait velocity
- Last Updated
- 10 years ago
Overview
Brief Summary
The beneficial effects of rhythmical auditory stimulation (RAS) on spatio-temporal gait characteristics in Parkinson's disease (PD) are attested by clinical research.
Nonetheless, it is still unclear which auditory information parameters (i.e. complexity, temporal regularity or adaptability to gait) maximize the effectiveness of RAS.
Objectives: To evaluate the beneficial effects of RAS on spatio-temporal gait characteristics in PD patients with gait disorders according to:
- RAS complexity (i.e. metronome, amplitude modulated noise, music)
- RAS variability (i.e fixed, random, semi-random)
- RAS adapted in real-time to gait
Variability study:
To study the impact of RAS variability (i.e fixed, random, semi-random) in 20 PD patients and 20 healthy controls on spatio-temporal gait characteristics with metronome, amplitude noise and music.
Adaptability studyTo study the impact of RAS adaptability (i.e fixed, random, adapted in real-time to gait) in 20 PD patients and 20 healthy controls on spatio-temporal gait characteristics with metronome, amplitude noise and music.
Investigators
Eligibility Criteria
Inclusion Criteria
- •to be able to understand the study aims and to agree to participate
- •to have signed the consent form
- •to be registered to social security system
- •to reach the diagnosis criteria of idiopathic PD (Queen Square Brain Bank)
- •gait disorder clinically observable
Exclusion Criteria
- •pregnant or lactating woman
- •high probability of non-compliance
- •curators , authorship or advisers to person of full age Specific exclusion criteria for PD patients
- •clinical signs of parkinsonian syndrome
- •Mini Mental State Examination \< 24/30 Specific exclusion criteria for controls
- •neurological disease
- •gait disorder
Outcomes
Primary Outcomes
gait velocity
Time Frame: 2 days
evaluation of walking speed between the different conditions
Secondary Outcomes
- spatio-temporal gait characteristics(2 days)